Almas Jabeen

Title: Almas Jabeen: Innovator in Anticancer and Anti-inflammatory Research

Introduction

Almas Jabeen is a prominent inventor based in Karachi, Pakistan. He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 2 patents to his name, Jabeen is recognized for his innovative approaches to combating cancer and inflammation.

Latest Patents

Jabeen's latest patents include groundbreaking work on anticancer peptides. His invention provides new anticancer analogs of the antimicrobial peptide temporin-SHa. The new analogs (SEQ ID NOs: 2-6) of temporin SHa, along with two different conjugates (7 & 8) comprising monomeric and dimeric forms of SEQ ID NO 4 with cancer-targeting ligands, have been identified as promising anticancer peptides. Additionally, he has developed an anti-inflammatory compound through the biotransformation of dianabol, yielding a metabolite known as 17β-hydroxy-17α-methyl-5α-androstan-3-one, which serves as a potent anti-inflammatory agent.

Career Highlights

Throughout his career, Almas Jabeen has focused on innovative research that addresses critical health challenges. His work has garnered attention in the scientific community, and he continues to explore new avenues for therapeutic development.

Collaborations

Jabeen has collaborated with notable colleagues, including Muhammad Iqbal Choudhary and Farzana Shaheen. These partnerships have enhanced his research efforts and contributed to the advancement of his projects.

Conclusion

Almas Jabeen stands out as a dedicated inventor whose work in anticancer and anti-inflammatory research has the potential to make a significant impact on healthcare. His innovative patents reflect his commitment to improving therapeutic options for patients.